Wedbush Reiterates Neutral on Vera Therapeutics, Maintains $35 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.8%

Neg 0% Neu 88.8% Pos 0%

Wedbush analyst Laura Chico reiterates Vera Therapeutics (NASDAQ:VERA) with a Neutral and maintains $35 price target.

Comments

No comments yet. Be the first!